Posts Tagged ‘NIH’

science_money04

I’ve posted the Lancet editor’s comments before, but here is more, and from the US National Institute of Health, no less:

Skeptical of medical science reports?

 

“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as editor of The New England Journal of Medicine
-Marcia Angell (New England Journal of Medicine)

“The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness”
-Richard Horton (Lancet)

And the WHY:

The first article showed how the relationships between pharmaceutical companies and academic physicians at prestigious universities impacted certain drug-related publications and the marketing of prescription drugs. Potential conflicts of interest seemed to abound: millions of dollars in consulting and speaking fees to physicians who promoted specific drugs, public research dollars being used by a researcher to test a drug owned by a company in which the researcher held millions of dollars in shares, failure of university researchers to disclose income from drug companies, company subsidies to physician continuing education, publishing practice guidelines involving drugs in which the authors have a financial interest, using influential physicians to promote drugs for unapproved uses, bias in favor of a product coming from failure to publish negative results and repeated publication of positive results in different forms.

 

Reality strikes again.

19027731

New Report From The NEJM On Clinical Trial Reporting Further Tarnishes Biopharma’s Image

New England Journal of Medicine destroys the bullshit monkey wrenching of pharmaceutical trials and cover-up. It’s difficult to find any aspect of our top-down corporatocracy that isn’t completely full of shit and running on fraud and propaganda.

The action may put a stop to the practice of cherry picking outcomes for public disclosure. An investigation published in March found that during the following 12 months after completion of industry funded trials, only 17% of trial outcomes had been reported.

This number increased to just 41% after five years. Results for the trials funded by the National Institutes of Health produced only 8% disclosure after 12 months, and 38% after five yearsIt is logical to assume that the results presented to the public were supportive of study hypotheses.

Public-Health-Funding.0